Sofradir and ULIS to invest €150M in French Nano 2022 program, part of EU initiative on microelectronics
CarThera obtains ANSM approval to launch its Phase I-II clinical trial for the SonoCloud-9 device in the treatment of recurrent glioblastoma
Minoryx Therapeutics extends its activities in Belgium
Biomunex signs a licensing agreement with Sanofi for the development of bi- and multi-specific antibodies
Robocath’s R-One™ robot acquired by the Medical Training & Testing Center in Rouen for future healthcare practitioner training
Genopole lance l’appel à candidatures de la 4e promotion du Shaker et du Booster
Germitec appoints David Radford as non-executive director and board member
Jean-François Delepau, président de Sofradir et ULIS, reçoit le Chaptal du Comité des Arts Physiques 2018
